CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Immuron Limited Company Snapshot
Immuron Limited operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Immuron Limited with three other pharmaceutical manufacturers in Australasia: Prescient Therapeutics Ltd (2021 sales of 66,285.00 Australian Dollars [US$49,136.41 ] of which 100% was Clinical stage oncology), Auscann Group Holdings Ltd (232,675.00 Australian Dollars [US$172,479.65 ] of which 100% was Research and development of medicinal ca), and Genetic Technologies Limited (120,554.00 Australian Dollars [US$89,365.47 ] ).

Sales Analysis. Sales fell dramatically in 2021: During the year ended June of 2021, sales at Immuron Limited were A$145,776.00 (US$108.06 thousand). This is a sharp decrease of 94.2% versus 2020, when the company's sales were A$2.52 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Immuron Limited
  Stock Performance Chart for Immuron Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (10/15/2021): .13
(Figures in Australian Dollars)
1 Week -16.1%   13 Weeks n/a  
4 Weeks n/a   52 Weeks -50.9%  
 
Immuron Limited Key Data:
  Ticker: IMC Country: Australia
  Exchanges: OTC BLN ASX Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2021 Sales 145,776
(Year Ending Jan 2022).
Employees: 25
  Currency: Australian Dollars Market Cap: 29,542,057
  Fiscal Yr Ends: June Shares Outstanding: 227,246,596
  Share Type: Ordinary Closely Held Shares: 40,962,904
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.